CDC Leadership Accountability Act of 2023

This bill would require the Director of the Centers for Disease Control and Prevention (CDC) to be appointed by the President and confirmed by the Senate. While a previous law already scheduled this change to take effect in 2025, H.R. 3813 moves that start date up to June 1, 2023. Under this legislation, any individual appointed to lead the CDC during the transition period would serve in an "acting" capacity until they undergo the formal Senate confirmation process.

For citizens, this change increases legislative oversight of the CDC by giving the Senate the power to vet and vote on the agency's leadership, rather than allowing the Director to be appointed solely by the President. Proponents of the shift argue it increases public accountability for the nation’s top health official, while the bill specifically ensures that current or recent leadership transitions are subject to these stricter confirmation requirements immediately.